review · Expert Review of Clinical Immunology

An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis

Abdullah Alkattan
Noura Alrasheed
Dina Alhabib
Afnan Younis
Nadia Suraj
Eman Alsalameen
Abrar Alzaher
Elham Alsalem
Moneerah Abdullah Almuhaidib
Mona Ibrahim

20243 citationsZagazig University

Abstract

Delgocitinib and ruxolitinib demonstrated favorable safety and effectiveness profiles across various age cohorts, whereas crisaborole raised concerns over its safety and efficacy, particularly in children.

Research topics

Dermatology and Skin Diseases
Allergic Rhinitis and Sensitization
Food Allergy and Anaphylaxis Research

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1080/1744666x.2024.2435657

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.